Presentation download: Molecular Painting: a novel method for biomembrane surface modification with wide-reaching applications

The Managing Director of Anovasia, John Dangerfield shared a unique platform technology called Molecular Painting (MP) at the World Vaccine Congress Asia. He defined MP as the surface modification of biomembranes and MP reagents are based on natural products.  The main industrial application areas are: Basic and Applied Research Diagnostics, Biomarkers Vaccine Development Targeting and Delivery of Genes, Proteins and/or …

Therapeutic vaccines– An introduction of Digital Personal Medicine (DPM) with DermaVir

Dr Julianna Lisziewicz, the President, CEO and Vice President of Research, GeneticImmunity joined us at the 12th annual World Vaccine Congress Washington in April 2012 to talk about GeneticImmunity's very interesting take on personalizing vaccines.   Dr Lisziewicz talked us through her views on why we need to personalize DermaVir and other therapeutic vaccines and presented the DPM concept and …

How can breakthrough technology serve the emerging markets?

In January 2010 Johan Van Hoof was appointed Global Therapeutic Area Head for Infectious Diseases & Vaccines, Pharmaceuticals Group, JnJ. As of June 2011, Johan took additional responsibilities, as COO Crucell, the Vaccine Company acquired by JnJ in February 2011. In this role he oversees Development and Manufacturing as Crucell. Entering the field of vaccines, J&J aims to broaden its …